Dalacin C Phosphat 300 mg
Dalacin C Phosphat 300 mg is a medicine authorised by Swissmedic under authorisation number 38978. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 July 1975 and the authorisation is valid without a time limit. ATC code J01FF01 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 38978 |
|---|---|
| Name | Dalacin C Phosphat 300 mg |
| Full name | Dalacin C Phosphat 300 mg, Injektionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01FF01 |
| First authorisation | 11 July 1975 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dalacin C Phosphat 300 mg, Injektionslösung | A | 11 July 1975 |
| 2 | Dalacin C Phosphat 600 mg, Injektionslösung | A | 11 July 1975 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 71 | 1 x 2 | ml | J01FF01 | 08.01.92 | A |
| 98 | 10 x 2 | ml | J01FF01 | 08.01.92 | A |
| 101 | 1 x 4 | ml | J01FF01 | 08.01.92 | A |
| 128 | 10 x 4 | ml | J01FF01 | 08.01.92 | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dalacin C Phosphat 300 mg authorised in Switzerland?
Yes. Dalacin C Phosphat 300 mg is authorised by Swissmedic under authorisation number 38978, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dalacin C Phosphat 300 mg have?
Dalacin C Phosphat 300 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Dalacin C Phosphat 300 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.